(1 - 14 von 25
)
Cevec raises €4M to develop human protein expression ...Science|Business
sciencebusiness.net
Karlheinz Schmelig, Managing Director of Creathor Venture Management GmbH, said, “The global protein production market is ready for a high performance human ... Karlheinz Schmelig, Managing Director of Creathor Venture Management GmbH, said, “The global protein production market is ready for a high performance human ...
The annual general meeting in Prostatype Genomics AB ...Nasdaq
view.news.eu.nasdaq.com
— ... Karlheinz Schmelig and Håkan Englund as members of the board of directors. Further, Mattias Prage was elected as new member of the board — ... Karlheinz Schmelig and Håkan Englund as members of the board of directors. Further, Mattias Prage was elected as new member of the board ...
Venture Capital for Caprotec Bioanalytics - NewsWISTA Management GmbH
www.wista.de
— Köster has developed a technology that has enormous potential”, says Karlheinz Schmelig, Managing Director at Creathor Venture. “Moreover — Köster has developed a technology that has enormous potential”, says Karlheinz Schmelig, Managing Director at Creathor Venture. “Moreover ...
caprotec bioanalytics Completes Series B Financing Round of EUR 4...
www.analytica-world.com
Karlheinz Schmelig, Managing Director at Creathor Venture commented, “The completion of this investment round in a challenging financing environment demonstrates that caprotec, with its exceptional management and ground breaking new technology, stands out among other companies in …
sortiert nach Relevanz / Datum